The AI POV — All Articles
Shaheen’s AI Hearing Is a Preview of the Regulatory Fight Silicon Valley Fears
Shaheen's focus on Anthropic signals that Congress will use the Pentagon controversy as a wedge to push broader AI regulation…
Pixar’s Cowardice Defense Reveals Disney’s Real Stance on Representation
Docter's framing of queer content as therapy rather than storytelling exposes that Disney's inclusive rhetoric is marketing, not corporate policy.
The Bride Flop Proves Warner-Paramount Merger Is Desperation, Not Strategy
The Bride's $7.3 million opening — a $75 million loss — exposes the Warner-Paramount merger as a balance-sheet play, not…
Wet Wipe Bacterium Deaths Expose Regulatory Gaps in Everyday Product Safety
Six deaths linked to contaminated wet wipes expose how consumer product regulation lags behind the risks in products found in…
Elio’s Cut Queer Future Proves Pixar Chose Box Office Over Authenticity
Pixar cut Elio's queer storyline to avoid market backlash. The film lost $100 million anyway. The studio chose box office…
Scandal Fatigue Is the Weapon Politicians Use to Survive Their Own Misconduct
Scandal fatigue is not voter exhaustion — it is a weapon. Politicians survive misconduct because party leaders close ranks and…
Pentagon AI Deals Will Choke Defense Innovation While China Moves Unchecked
The Pentagon's blacklist of Anthropic signals that Silicon Valley startups that refuse unrestricted military AI access will be punished—while China…
OpenAI Robotics Exit Exposes the Real Cost of Selling AI to the Pentagon
OpenAI's robotics chief resigned over the rushed Pentagon deal. The real cost is lost talent and innovation, not just user…
ChatGPT Uninstalls Prove Consumer AI and Defense AI Cannot Coexist in One Brand
ChatGPT uninstalls surged 295% after the Pentagon deal. Consumer AI and defense AI cannot coexist in one brand.
Trump’s Roundup Order Hands Bayer a Legal Shield While Farmers Bear the Risk
Trump's glyphosate order protects Bayer's Roundup revenue while farmers and communities bear the risk. The timing with Bayer's settlement is…